Transphorm Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	18.76	16.51	24.05	11.37	11.93	1.36
Revenue Growth (YoY)	2.79%	-31.35%	111.50%	-4.72%	778.79%	-
Cost of Revenue	15.24	17.46	12.53	6.68	6.49	4.6
Gross Profit	3.51	-0.95	11.52	4.69	5.44	-3.24
Selling, General & Admin	22.31	18.92	14.76	12.5	9.22	9.3
Research & Development	11.74	8.91	6.66	5.58	8.15	9.35
Operating Expenses	34.05	27.83	21.42	18.09	17.36	18.65
Operating Income	-30.54	-28.78	-9.9	-13.4	-11.92	-21.9
Interest Expense / Income	0.19	0.73	0.79	0.76	0.76	0.71
Other Expense / Income	2.64	1.09	-0.45	3.75	2.61	3.19
Pretax Income	-33.37	-30.6	-10.24	-17.91	-15.28	-25.8
Net Income	-33.37	-30.6	-10.24	-17.91	-15.28	-25.8
Preferred Dividends	8.33	0	0	0	0	0
Shares Outstanding (Basic)	62	56	46	32	28	4
Shares Outstanding (Diluted)	62	56	46	32	28	4
Shares Change	9.60%	22.08%	45.11%	12.74%	567.21%	-
EPS (Basic)	-0.70	-0.54	-0.22	-0.56	-0.54	-6.11
EPS (Diluted)	-0.70	-0.54	-0.22	-0.56	-0.54	-6.11
Free Cash Flow	-24.16	-33.33	-20.33	-14.17	-12.49	-18.02
Free Cash Flow Per Share	-0.39	-0.59	-0.44	-0.45	-0.44	-4.27
Gross Margin	18.73%	-5.75%	47.90%	41.24%	45.60%	-238.81%
Operating Margin	-162.84%	-174.29%	-41.15%	-117.82%	-99.87%	-1612.30%
Profit Margin	-222.34%	-185.32%	-42.56%	-157.50%	-128.06%	-1899.71%
Free Cash Flow Margin	-128.84%	-201.89%	-84.54%	-124.64%	-104.68%	-1326.73%
EBITDA	-31.48	-28.33	-8.6	-16.31	-13.31	-23.71
EBITDA Margin	-167.85%	-171.61%	-35.76%	-143.47%	-111.52%	-1746.24%
Depreciation & Amortization	1.7	1.53	0.84	0.84	1.22	1.37
EBIT	-33.18	-29.87	-9.44	-17.15	-14.53	-25.09
EBIT Margin	-176.91%	-180.90%	-39.26%	-150.81%	-121.71%	-1847.42%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).